logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use and primary drug. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (vii) Age at first use distribution, All inpatient clients (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates8.443.727.211.55.12.31.00.721.4122541102
Cocaine11.544.722.411.15.13.21.10.821.21855316
Stimulants15.459.216.35.02.60.90.30.319.03550241
Hypnotics and sedatives9.427.019.112.711.86.15.38.526.8936336
Hallucinogens10.057.120.011.41.40.00.00.019.57021
Volatile substances39.744.98.13.81.70.90.40.417.423413
Cannabis 44.545.06.62.10.80.30.40.116.64290577
Other substances 17.531.618.414.09.44.41.82.822.91196496
Total16.845.120.78.94.42.01.01.020.4243853102
 

Notes:

The number of treatment clients in each country is listed in Table TDI-7.

See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI — outpatient treatment centres.

Page last updated: Friday, 26 April 2013